DoW Peer Reviewed Medical, Impact Award
DoW Peer Reviewed Medical, Impact Award is a published development and funding opportunity on Contexium. The donor or funder is Defense Health Agency Contracting Activity - DHACA. Project location(s): United States. Applications close on 06 Aug 2026. Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Impact Award supports applied research, defined as use-inspired and practice-oriented science that brings together outcomes from basic research, and insights from the real-world environment, to foster clinical applic…
Opportunity overview
- Project name
- DoW Peer Reviewed Medical, Impact Award
- Donor
- Defense Health Agency Contracting Activity - DHACA
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
Summary
Frequently asked questions
What is DoW Peer Reviewed Medical, Impact Award?
DoW Peer Reviewed Medical, Impact Award is a published development and funding opportunity on Contexium. The donor or funder is Defense Health Agency Contracting Activity - DHACA. Project location(s): United States. Applications close on 06 Aug 2026. Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Impact Award supports applied research, defined as use-inspired and practice-oriented science that brings together outcomes from basic research, and insights from the real-world environment, to foster clinical applic…
Who is funding DoW Peer Reviewed Medical, Impact Award?
DoW Peer Reviewed Medical, Impact Award is funded by Defense Health Agency Contracting Activity - DHACA.
When is the deadline to apply for DoW Peer Reviewed Medical, Impact Award?
The application deadline is 06 Aug 2026 00:00 (UTC).
Where will the DoW Peer Reviewed Medical, Impact Award project take place?
The project location(s) are: United States.
How can I apply for DoW Peer Reviewed Medical, Impact Award?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.